Anne-Marie Duliege
CIK 1419579 · EVP & Chief Medical Officer · last filed 2019-03-22
Anne-Marie Duliege is an EVP & Chief Medical Officer who has filed 33 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for RIGL, was dated Mar 22, 2019. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.79M
3
33
-$2.96M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | EVP & Chief Medical Officer | 115,500 | $32.85 | $3.79M | -$653.3K | 12 | 2019-03-22 |
| CCXI | EVP, Chief of Strategic Dev. | 0 | $10.22 | $0 | -$23.4K | 2 | 2014-11-20 |
| AFFYMAX INC (AFFY) Delisted | Chief Medical Officer | 28,125 | — | — | -$2.28M | 19 | 2013-02-01 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-22 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2019-01-25 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2018-09-19 | RIGL | Mixed | — | -$163.0K | EDGAR |
| 2018-09-06 | RIGL | Mixed | — | -$16.0K | EDGAR |
| 2018-07-05 | RIGL | Sell (S) | −5,000 | -$13.9K | EDGAR |
| 2018-05-11 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2018-04-24 | RIGL | Sell (S) | −5,000 | -$20.6K | EDGAR |
| 2018-01-26 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2017-07-07 | RIGL | Sell (S) | −5,000 | -$13.4K | EDGAR |
| 2017-02-06 | RIGL | Grant (A) | — | $0 | EDGAR |